Thursday
SESSION 19: CRITICAL EVALUATION OF CAROTID ARTERY STENTING (CAS) IN NOVEMBER 2012: WHERE IS IT AND WHERE IS IT GOING
Moderators:Giorgio M. Biasi, MD / Frank J. Veith, MD  
SESSION 19 SCHEDULE
2:12 PM - 2:17 PM Why MRI Should Be Done Before All Revascularization Procedures (CAS And CEA): Duplex Is Not Enough
  Presenter(s):Emmanuel M. Houdart, MD  
2:18 PM - 2:23 PM Closed vs. Open Cell Stents For CAS: The Number Of Embolic Particles Are No Greater Nor Are Outcomes Worse With Open Cell Stents
  Presenter(s):Peter L. Faries, MD, FACS  
2:24 PM - 2:29 PM CAS For Total Carotid Occlusion: It Can Work And Be Beneficial: Under What Circumstances
  Presenter(s):Paul H.L. Kao, MD  
2:30 PM - 2:35 PM DEBATE: CAS Is Good Treatment For Most Patients With Symptomatic And Asymptomatic Carotid Stenosis
  Presenter(s):Klaus D. Mathias, MD  
2:36 PM - 2:41 AM DEBATE: CAS Is Not Good Treatment For Most Patients With Symptomatic And Asymptomatic Carotid Stenosis
  Presenter(s):Bruce A. Perler, MD, MBA  
  View Abstract      
2:42 PM - 2:47 PM Is Current Best Medical Treatment (BMT) Feasible And Does It Work To Decrease Strokes From Intracranial Disease In A High Risk Population: Results From The SAMMPRIS Trial Suggest BMT Can Decrease Strokes Markedly
  Presenter(s):Marc Chimowitz, MD  
2:48 PM - 2:53 PM Analysis Of CREST By A Neuroradiologist: What Is The Significance Of A Minor Stroke
  Presenter(s):Emmanuel M. Houdart, MD  
2:54 PM - 2:59 PM DEBATE: Cardiac Events Are An Appropriate End-Point For Evaluating CAS vs. CEA Outcomes; And In CREST, CAS Results Improved With Time
  Presenter(s):William A. Gray, MD  
3:00 PM - 3:05 PM DEBATE: Cardiac Events Are Not An Appropriate End-Point For Evaluating CAS vs. CEA Outcomes; And In CREST, CAS Results Did Not Improve With Time
  Presenter(s):Wesley S. Moore, MD  
  View Abstract      
3:06 PM - 3:11 PM Interventions Performed Within 1 Week Of A Neurological Event: Outcomes Of CEA Are Better Than CAS
  Presenter(s):Hans-Henning Eckstein, MD, PhD  
3:12 PM - 3:17 PM The Case Against Embolic Protection Devices In CAS: Why Therefore Are They So Widely Used
  Presenter(s):Michel S. Makaroun, MD  
3:18 PM - 3:23 PM Meta-Analysis Of CAS By Cervical Access Shows Dramatic Reduction In Neurological Events
  Presenter(s):Patrice F. Bergeron, MD / Petrosian Andranik, MD  
3:24 PM - 3:29 PM A Specialized Device For Performing CAS Via A Cervical Approach With Flow Reversal (FAST-CAS System): Early Results From The PROOF Trial
  Presenter(s):Ralf R. Kolvenbach, MD  
  View Abstract      
3:30 PM - 3:35 PM DEBATE: Why Is It Difficult To Randomize Asymptomatic Carotid Stenosis Patients To A 3-Armed Trial: CEA vs. CAS vs. BMT
  Presenter(s):Hans-Henning Eckstein, MD, PhD  
3:36 PM - 3:41 PM DEBATE:Why We Must Have A Trial Comparing BMT To CAS And CEA In Asymptomatic Patients With Carotid Stenosis
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP, FRACP  
  View Abstract      
3:42 PM - 3:47 PM TCD Embolic Signals, Silent Infarcts On CT-Brain Scans, Or The Size Of Juxtaluminal Black Area In Evaluating Stroke Potential Of Asymptomatic Carotid Lesions
  Presenter(s):Andrew N. Nicolaides, MS, FRCS  
  View Abstract      
3:48 PM - 4:00 PM Panel Discussion And Break
Visit Exhibits and Pavilions (2nd and 3rd Floors)
END OF SESSION 19
previous next